GT Biopharma Inc. (NASDAQ: GTBP) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT GT BIOPHARMA INC.

GT Biopharma Inc. (NASDAQ: GTBP)
Listen to this Section


$0.44
+0.0105 ( +2.47% ) 936.0K

GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of immuno-oncology therapeutic products based on our proprietary TriKE ® NK cell engager platform. Our TriKE ® platform is designed to harness and enhance the cancer killing abilities of a patient's immune system's natural killer cells. GT Biopharma has an exclusive worldwide license agreement with the University of Minnesota to further develop and commercialize therapies using TriKE ® technology.

Market Data


Open $0.44
Previous Close $0.43
Volume 936.0K
Market Cap $15.33M
Day Range $0.41 - $0.47
52 Week Range $0.26 - $2.29
Shares Outstanding 36.06M
Change % +2.47%
Net Change ▲ 0.0105
Insider Ownership 0.00%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year2021
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: -400,000.00

Date Type Amount Purchased Purchaser
2023-08-15 Sale -200000.00 Ohri Manu
2023-08-15 Sale -200000.00 Breen Michael Martin

SEC Filings


Form Type Description Pages Date
8-k 8K-related 13 Aug 29, 2025
10-q Quarterly Reports 68 Aug 14, 2025
3 Insider transactions 1 Jul 30, 2025
8-k 8K-related 12 Jul 24, 2025
424b3 Other 2 Jul 03, 2025

Latest News